| Future Health Pharma GmbH - Xermelo 250 mg, Filmtabletten | | 66374 | | 01 | | Xermelo 250 mg | | Filmtabletten | | A16AX15 | | Telotristat | | 28.03.2018 | | |
| | Composition | | ethylis telotristatas 250 mg ut telotristati etipras 327.9 mg corresp. telotristatum 237.80 mg, lactosum 167.91 mg, hydroxypropylcellulosum, carmellosum natricum conexum, natrium 4.54 mg, magnesii stearas, silica colloidalis, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Ethylis Telotristatas | 250 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Lactosum | 167.91 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Sodium | 4.54 mg | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 90 | DDP | DDP | B | | Oui |
|
|
